Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases pose significant health challenges due to neuron ...

Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor ...

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

Constant tremors, difficulty standing and walking, mental disorders, and sleep disturbances are all symptoms of Parkinson's ...

An experimental immunotherapy candidate targets toxic species of alpha-synuclein and was well tolerated in an ongoing, ...

Slow movement, tremor, and stiff muscles are all typical symptoms of Parkinson’s disease. They are due to loss of the ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...

Needham analyst Ami Fadia has reiterated their neutral stance on SAGE stock, giving a Hold rating today. Ami Fadia has given his Hold rating ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Gain’s lead program in Parkinson’s disease has been awarded funding support from The ... to the offerings and the use of proceeds from the offerings. For a further description of the risks and ...

The center's services will be free for patients with Parkinson's, a neurological disease that afflicts more than 1 million people in the United States, including 8,000 in Metro Detroit.